Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Barker

Showing results (31-40 of 452) with videos related to

Pageof 46
Sort By:
Cell Stem Cell|August 5, 2010
Graft-induced dyskinesias in Parkinson's disease: what is it all about?Roger A Barker, Wei-Li Kuan
Journal of Hematotherapy & Stem Cell Research|February 24, 2004
The future of cell-based transplantation therapies for neurodegenerative disordersStanley E Lazic, Roger A Barker
Expert Review of Neurotherapeutics|June 10, 2011
Cell-based therapies for Parkinson's diseaseSean C Dyson, Roger A Barker
Journal of Neurology|April 9, 2010
Parkinson's disease and 2009: recent advancesDavid P Breen, Roger A Barker
Expert Opinion on Emerging Drugs|May 21, 2009
Emerging drug therapies in Huntington's diseaseSarah L Mason, Roger A Barker
Neuroreport|October 27, 2011
Dopamine stimulates epidermal growth factor release from adult neural precursor cells derived from the subventricular zone by a disintegrin and metalloproteaseGráinne C O'Keeffe, Roger A Barker
Neuroreport|October 23, 2013
The challenges of administering cell-based therapies to patients with Parkinson's diseaseJanelle Drouin-Ouellet, Roger A Barker
Journal of Huntington'S Disease|January 15, 2019
Disease-Modification in Huntington's Disease: Moving Away from a Single-Target ApproachMelanie P Jensen, Roger A Barker
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 31, 2020
Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?Philip C Buttery, Roger A Barker
Handbook of Clinical Neurology|September 28, 2024
Disease-specific interventions: The use of cell and gene therapies for Parkinson diseaseRoger A Barker, Philip C Buttery
Pageof 46

Showing results (31-40 of 452) with videos related to

Sort By:
Pageof 46
Cell Stem Cell|August 5, 2010
Graft-induced dyskinesias in Parkinson's disease: what is it all about?Roger A Barker, Wei-Li Kuan
Journal of Hematotherapy & Stem Cell Research|February 24, 2004
The future of cell-based transplantation therapies for neurodegenerative disordersStanley E Lazic, Roger A Barker
Expert Review of Neurotherapeutics|June 10, 2011
Cell-based therapies for Parkinson's diseaseSean C Dyson, Roger A Barker
Journal of Neurology|April 9, 2010
Parkinson's disease and 2009: recent advancesDavid P Breen, Roger A Barker
Expert Opinion on Emerging Drugs|May 21, 2009
Emerging drug therapies in Huntington's diseaseSarah L Mason, Roger A Barker
Neuroreport|October 27, 2011
Dopamine stimulates epidermal growth factor release from adult neural precursor cells derived from the subventricular zone by a disintegrin and metalloproteaseGráinne C O'Keeffe, Roger A Barker
Neuroreport|October 23, 2013
The challenges of administering cell-based therapies to patients with Parkinson's diseaseJanelle Drouin-Ouellet, Roger A Barker
Journal of Huntington'S Disease|January 15, 2019
Disease-Modification in Huntington's Disease: Moving Away from a Single-Target ApproachMelanie P Jensen, Roger A Barker
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 31, 2020
Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?Philip C Buttery, Roger A Barker
Handbook of Clinical Neurology|September 28, 2024
Disease-specific interventions: The use of cell and gene therapies for Parkinson diseaseRoger A Barker, Philip C Buttery
Pageof 46